Source: https://regulations.justia.com/regulations/fedreg/2007/11/15/E7-22386.html
Timestamp: 2020-08-10 00:00:52
Document Index: 766668050

Matched Legal Cases: ['art 712', 'arts 710', 'art 712', 'art 745', 'art 712', 'arts 710', 'art 712', 'art 745']

Impact of Implementation of the Chemical Weapons Convention on Commercial Activities Involving “Schedule 1” Chemicals During Calendar Year 2007, 64193-64194 [E7-22386] :: Industry And Security Bureau :: Department Of Commerce :: Regulation Tracker :: Justia
Justia Regulation Tracker Department Of Commerce Industry And Security Bureau Impact of Implementation of the Chemical Weapons Convention on Commercial Activities Involving “Schedule 1” Chemicals During Calendar Year 2007, 64193-64194 [E7-22386]
Impact of Implementation of the Chemical Weapons Convention on Commercial Activities Involving “Schedule 1” Chemicals During Calendar Year 2007, 64193-64194 [E7-22386]
Download as PDF Federal Register / Vol. 72, No. 220 / Thursday, November 15, 2007 / Notices II. Method of Collection DEPARTMENT OF COMMERCE This information will be collected by mail, fax, and telephone follow-up. Bureau of Industry and Security III. Data [Docket No. 071107679–7690–01] OMB Control Number: 0607–0717. Form Number: SM–44(06)S, SM– 44(06)SE, SM–44(06)SS, SM–44(06)B, SM–44(06)BE, SM–44(06)BS, SM– 45(06)S, SM–45(06)SE, SM–45(06)SS, SM–45(06)B, SM–45(06)BE, SM– 45(06)BS, SM–72(06)S, and SM–20(06)I. Type of Review: Regular submission. Affected Public: Retail and Food Services firms in the United States. Estimated Number of Respondents: 10,000. Estimated Time Per Response: 7 minutes. Estimated Total Annual Burden Hours: 14,000. Estimated Total Annual Cost: $367,640. Respondent’s Obligation: Voluntary. Legal Authority: Title 13 U.S.C. Section 182. Impact of Implementation of the Chemical Weapons Convention on Commercial Activities Involving ‘‘Schedule 1’’ Chemicals During Calendar Year 2007 IV. Request for Comments pwalker on PROD1PC71 with NOTICES Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden (including hours and cost) of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Comments submitted in response to this notice will be summarized and/or included in the request for OMB approval of this information collection; they also will become a matter of public record. Dated: November 7, 2007. Gwellnar Banks, Management Analyst, Office of the Chief Information Officer. [FR Doc. E7–22234 Filed 11–14–07; 8:45 am] BILLING CODE 3510–07–P VerDate Aug<31>2005 19:50 Nov 14, 2007 Jkt 214001 Bureau of Industry and Security, Commerce. ACTION: Notice of inquiry. AGENCY: SUMMARY: The Bureau of Industry and Security (BIS) is seeking public comments on the impact that implementation of the Chemical Weapons Convention, through the Chemical Weapons Convention Implementation Act and the Chemical Weapons Convention Regulations, has had on commercial activities involving ‘‘Schedule 1’’ chemicals during calendar year 2007. The purpose of this notice of inquiry is to collect information to assist BIS in its preparation of the annual certification to the Congress, which is required under Condition 9 of Senate Resolution 75, April 24, 1997, in which the Senate gave its advice and consent to the ratification of the Chemical Weapons Convention. DATES: Comments must be received by December 17, 2007. ADDRESSES: You may submit comments by any of the following methods: E-mail: wfisher@bis.doc.gov. Include the phrase ‘‘Schedule 1 Notice of Inquiry’’ in the subject line; Fax: (202) 482–3355 (Attn: Willard Fisher); Mail or Hand Delivery/Courier: Willard Fisher, U.S. Department of Commerce, Bureau of Industry and Security, Regulatory Policy Division, 14th Street & Pennsylvania Avenue, NW., Room 2705, Washington, DC 20230. For questions on the Chemical Weapons Convention requirements for ‘‘Schedule 1’’ chemicals, contact Timir Misra, Treaty Compliance Division, Office of Nonproliferation and Treaty Compliance, Bureau of Industry and Security, U.S. Department of Commerce, Phone: (703) 605–4400. For questions on the submission of comments, contact Willard Fisher, Regulatory Policy Division, Office of Exporter Services, Bureau of Industry and Security, U.S. Department of Commerce, Phone: (202) 482–2440. SUPPLEMENTARY INFORMATION: FOR FURTHER INFORMATION CONTACT: PO 00000 Frm 00003 Fmt 4703 Sfmt 4703 64193 Background In providing its advice and consent to the ratification of the Convention on the Prohibition of the Development, Production, Stockpiling, and Use of Chemical Weapons and Their Destruction, commonly called the Chemical Weapons Convention (CWC) (the Convention), the Senate included, in Senate Resolution 75 (S. Res. 75, April 24, 1997), several conditions to its ratification. Condition 9, titled ‘‘Protection of Advanced Biotechnology,’’ calls for the President to certify to Congress on an annual basis that ‘‘the legitimate commercial activities and interests of chemical, biotechnology, and pharmaceutical firms in the United States are not being significantly harmed by the limitations of the Convention on access to, and production of, those chemicals and toxins listed in Schedule 1.’’ On July 8, 2004, President Bush, by Executive Order 13346, delegated his authority to make the annual certification to the Secretary of Commerce. The CWC is an international arms control treaty that contains certain verification provisions. In order to implement these verification provisions, the CWC established the Organization for the Prohibition of Chemical Weapons (OPCW). The CWC imposes certain obligations on countries that have ratified the Convention (i.e., States Parties), among which are the enactment of legislation to prohibit the production, storage, and use of chemical weapons, and the establishment of a National Authority to serve as the national focal point for effective liaison with the OPCW and other States Parties for the purpose of achieving the object and purpose of the Convention and the implementation of its provisions. The CWC also requires each State Party to implement a comprehensive data declaration and inspection regime to provide transparency and to verify that both the public and private sectors of the State Party are not engaged in activities prohibited under the CWC. ‘‘Schedule 1’’ chemicals consist of those toxic chemicals and precursors set forth in the CWC ‘‘Annex on Chemicals’’ and in Supplement No. 1 to part 712 of the Chemical Weapons Convention Regulations (CWCR) (15 CFR parts 710–722). The CWC identified these toxic chemicals and precursors as posing a high risk to the object and purpose of the Convention. The CWC restricts the production of ‘‘Schedule 1’’ chemicals for protective purposes to two facilities per State Party. The CWC Article-by-Article Analysis submitted to the Senate in E:\FR\FM\15NON1.SGM 15NON1 pwalker on PROD1PC71 with NOTICES 64194 Federal Register / Vol. 72, No. 220 / Thursday, November 15, 2007 / Notices Treaty Doc. 103–21 defined the term ‘‘protective purposes’’ to mean ‘‘used for determining the adequacy of defense equipment and measures.’’ Consistent with this definition, U.S. implementation, as authorized via Presidential Decision Directive (PDD) 70, December 17, 1999, assigned the responsibility to operate these two facilities to the Department of Defense (DOD), thereby precluding commercial production of Schedule 1 chemicals for protective purposes in the United States. This action did not establish any limitations on ‘‘Schedule 1’’ chemical activities that are not prohibited by the CWC. However, the Department of Defense maintains strict controls on ‘‘Schedule 1’’ chemicals produced at its facilities in order to ensure the accountability and proper use of such chemicals, consistent with the object and purpose of the Convention. The provisions of the CWC that affect commercial activities involving ‘‘Schedule 1’’ chemicals are implemented in the CWCR (see 15 CFR part 712) and in the Export Administration Regulations (EAR) (see 15 CFR 742.18 and 15 CFR part 745), both of which are administered by the Bureau of Industry and Security (BIS). Pursuant to CWC requirements, the CWCR restrict commercial production of Schedule 1 chemicals to research, medical, or pharmaceutical purposes. The CWCR also contain other requirements and prohibitions that apply to ‘‘Schedule 1’’ chemicals and/or ‘‘Schedule 1’’ facilities. Specifically, the CWCR: (1) Prohibit the import of ‘‘Schedule 1’’ chemicals from States not Party to the Convention (15 CFR 712.2(b)); (2) Require annual declarations by certain facilities engaged in the production of ‘‘Schedule 1’’ chemicals in excess of 100 grams aggregate per calendar year (i.e., declared ‘‘Schedule 1’’ facilities) for purposes not prohibited by the Convention (15 CFR 712.5(a)(1) and (a)(2)); (3) Require government approval of ‘‘declared Schedule 1’’ facilities (15 CFR 712.5(f)); (4) Provide that ‘‘declared Schedule 1’’ facilities are subject to initial and routine inspection by the Organization for the Prohibition of Chemical Weapons (15 CFR 712.5(e) and 716.1(b)(1)); (5) Require 200 days advance notification of establishment of new ‘‘Schedule 1’’ production facilities producing greater than 100 grams aggregate of ‘‘Schedule 1’’ chemicals per calendar year (15 CFR 712.4); (6) Require advance notification and annual reporting of all imports and VerDate Aug<31>2005 19:50 Nov 14, 2007 Jkt 214001 exports of ‘‘Schedule 1’’ chemicals to, or from, other States Parties to the Convention (15 CFR 712.6, 742.18(a)(1) and 745.1); and (7) Prohibit the export of ‘‘Schedule 1’’ chemicals to States not Party to the Convention (15 CFR 742.18(a)(1) and (b)(1)(ii)). Request for Comments In order to assist in determining whether the legitimate commercial activities and interests of chemical, biotechnology, and pharmaceutical firms in the United States are significantly harmed by the limitations of the Convention on access to, and production of, ‘‘Schedule 1’’ chemicals as described in this notice, BIS is seeking public comments on any effects that implementation of the Chemical Weapons Convention, through the Chemical Weapons Convention Implementation Act and the Chemical Weapons Convention Regulations, has had on commercial activities involving ‘‘Schedule 1’’ chemicals during calendar year 2007. In response to last year’s notice of inquiry, BIS received comments from two companies. To allow BIS to properly evaluate the significance of any harm to commercial activities involving ‘‘Schedule 1’’ chemicals, public comments submitted in response to this notice of inquiry should include both a quantitative and qualitative assessment of the impact of the CWC on such activities. Submission of Comments All comments must be submitted to the address indicated in this notice. The Department requires that all comments be submitted in written form. The Department encourages interested persons who wish to comment to do so at the earliest possible time. The period for submission of comments will close on December 17, 2007. The Department will consider all comments received before the close of the comment period. Comments received after the end of the comment period will be considered if possible, but their consideration cannot be assured. The Department will not accept comments accompanied by a request that a part or all of the material be treated confidentially because of its business proprietary nature or for any other reason. The Department will return such comments and materials to the persons submitting the comments and will not consider them. All comments submitted in response to this notice will be a matter of public record and will be available for public inspection and copying. The Office of Administration, Bureau of Industry and Security, U.S. PO 00000 Frm 00004 Fmt 4703 Sfmt 4703 Department of Commerce, displays public comments on the BIS Freedom of Information Act (FOIA) Web site at http://www.bis.doc.gov/foia. This office does not maintain a separate public inspection facility. If you have technical difficulties accessing this Web site, please call BIS’s Office of Administration, at (202) 482–1093, for assistance. Dated: November 8, 2007. Matthew S. Borman, Deputy Assistant Secretary for Export Administration. [FR Doc. E7–22386 Filed 11–14–07; 8:45 am] BILLING CODE 3510–33–P DEPARTMENT OF COMMERCE International Trade Administration [A–469–814] Chlorinated Isocyanurates From Spain: Final Results of Antidumping Duty Administrative Review Import Administration, International Trade Administration, Department of Commerce. SUMMARY: The Department of Commerce (‘‘Department’’ published its preliminary results of the administrative review of the antidumping duty order on chlorinated isocyanurates (‘‘chlorinated isos’’) from Spain on July 9, 2007. See Chlorinated Isocyanurates from Spain: Preliminary Results of Antidumping Duty Administrative Review, 72 FR 37189 (July 9, 2007) (‘‘Preliminary Results’’). The period of review (‘‘POR’’) is December 20, 2004, through May 31, 2006. We invited interested parties to comment on our Preliminary Results. Based on our analysis of the comments received, we have made changes to our calculations. The final dumping margins from this review are listed in the ‘‘Final Results of Review’’ section below. EFFECTIVE DATE: November 15, 2007. FOR FURTHER INFORMATION CONTACT: Thomas Martin, AD/CVD Operations, Office 4, Import Administration, International Trade Administration, U.S. Department of Commerce, 14th Street and Constitution Avenue, NW., Washington, DC 20230; telephone (202) 482–3936. SUPPLEMENTARY INFORMATION: On June 24, 2005, the Department published in the Federal Register an antidumping duty order on chlorinated isos from Spain. See Chlorinated Isocyanurates from Spain: Notice of Antidumping Duty Order, 70 FR 36502 (June 24, 2005) (‘‘Chlorinated Isos Order’’). On July 27, 2006, the Department published in the AGENCY: E:\FR\FM\15NON1.SGM 15NON1
[Pages 64193-64194]
[FR Doc No: E7-22386]
[Docket No. 071107679-7690-01]
Impact of Implementation of the Chemical Weapons Convention on
Commercial Activities Involving ``Schedule 1'' Chemicals During
SUMMARY: The Bureau of Industry and Security (BIS) is seeking public
comments on the impact that implementation of the Chemical Weapons
Convention, through the Chemical Weapons Convention Implementation Act
and the Chemical Weapons Convention Regulations, has had on commercial
activities involving ``Schedule 1'' chemicals during calendar year
2007. The purpose of this notice of inquiry is to collect information
to assist BIS in its preparation of the annual certification to the
Congress, which is required under Condition 9 of Senate Resolution 75,
April 24, 1997, in which the Senate gave its advice and consent to the
ratification of the Chemical Weapons Convention.
DATES: Comments must be received by December 17, 2007.
E-mail: wfisher@bis.doc.gov. Include the phrase ``Schedule 1 Notice
of Inquiry'' in the subject line;
Mail or Hand Delivery/Courier: Willard Fisher, U.S. Department of
Commerce, Bureau of Industry and Security, Regulatory Policy Division,
14th Street & Pennsylvania Avenue, NW., Room 2705, Washington, DC
FOR FURTHER INFORMATION CONTACT: For questions on the Chemical Weapons
Convention requirements for ``Schedule 1'' chemicals, contact Timir
Misra, Treaty Compliance Division, Office of Nonproliferation and
Treaty Compliance, Bureau of Industry and Security, U.S. Department of
Commerce, Phone: (703) 605-4400. For questions on the submission of
comments, contact Willard Fisher, Regulatory Policy Division, Office of
Exporter Services, Bureau of Industry and Security, U.S. Department of
Commerce, Phone: (202) 482-2440.
In providing its advice and consent to the ratification of the
Stockpiling, and Use of Chemical Weapons and Their Destruction,
commonly called the Chemical Weapons Convention (CWC) (the Convention),
the Senate included, in Senate Resolution 75 (S. Res. 75, April 24,
1997), several conditions to its ratification. Condition 9, titled
``Protection of Advanced Biotechnology,'' calls for the President to
certify to Congress on an annual basis that ``the legitimate commercial
activities and interests of chemical, biotechnology, and pharmaceutical
firms in the United States are not being significantly harmed by the
limitations of the Convention on access to, and production of, those
chemicals and toxins listed in Schedule 1.'' On July 8, 2004, President
Bush, by Executive Order 13346, delegated his authority to make the
annual certification to the Secretary of Commerce.
The CWC is an international arms control treaty that contains
certain verification provisions. In order to implement these
verification provisions, the CWC established the Organization for the
Prohibition of Chemical Weapons (OPCW). The CWC imposes certain
obligations on countries that have ratified the Convention (i.e.,
States Parties), among which are the enactment of legislation to
prohibit the production, storage, and use of chemical weapons, and the
establishment of a National Authority to serve as the national focal
point for effective liaison with the OPCW and other States Parties for
the purpose of achieving the object and purpose of the Convention and
the implementation of its provisions. The CWC also requires each State
Party to implement a comprehensive data declaration and inspection
regime to provide transparency and to verify that both the public and
private sectors of the State Party are not engaged in activities
prohibited under the CWC.
``Schedule 1'' chemicals consist of those toxic chemicals and
precursors set forth in the CWC ``Annex on Chemicals'' and in
Supplement No. 1 to part 712 of the Chemical Weapons Convention
Regulations (CWCR) (15 CFR parts 710-722). The CWC identified these
toxic chemicals and precursors as posing a high risk to the object and
The CWC restricts the production of ``Schedule 1'' chemicals for
protective purposes to two facilities per State Party. The CWC Article-
by-Article Analysis submitted to the Senate in
[[Page 64194]]
Treaty Doc. 103-21 defined the term ``protective purposes'' to mean
``used for determining the adequacy of defense equipment and
measures.'' Consistent with this definition, U.S. implementation, as
authorized via Presidential Decision Directive (PDD) 70, December 17,
1999, assigned the responsibility to operate these two facilities to
the Department of Defense (DOD), thereby precluding commercial
production of Schedule 1 chemicals for protective purposes in the
United States. This action did not establish any limitations on
``Schedule 1'' chemical activities that are not prohibited by the CWC.
However, the Department of Defense maintains strict controls on
``Schedule 1'' chemicals produced at its facilities in order to ensure
the accountability and proper use of such chemicals, consistent with
the object and purpose of the Convention.
The provisions of the CWC that affect commercial activities
involving ``Schedule 1'' chemicals are implemented in the CWCR (see 15
CFR part 712) and in the Export Administration Regulations (EAR) (see
15 CFR 742.18 and 15 CFR part 745), both of which are administered by
the Bureau of Industry and Security (BIS). Pursuant to CWC
requirements, the CWCR restrict commercial production of Schedule 1
chemicals to research, medical, or pharmaceutical purposes. The CWCR
also contain other requirements and prohibitions that apply to
``Schedule 1'' chemicals and/or ``Schedule 1'' facilities.
Specifically, the CWCR:
(1) Prohibit the import of ``Schedule 1'' chemicals from States not
Party to the Convention (15 CFR 712.2(b));
(2) Require annual declarations by certain facilities engaged in
the production of ``Schedule 1'' chemicals in excess of 100 grams
aggregate per calendar year (i.e., declared ``Schedule 1'' facilities)
for purposes not prohibited by the Convention (15 CFR 712.5(a)(1) and
(a)(2));
(3) Require government approval of ``declared Schedule 1''
facilities (15 CFR 712.5(f));
(4) Provide that ``declared Schedule 1'' facilities are subject to
initial and routine inspection by the Organization for the Prohibition
of Chemical Weapons (15 CFR 712.5(e) and 716.1(b)(1));
(5) Require 200 days advance notification of establishment of new
``Schedule 1'' production facilities producing greater than 100 grams
aggregate of ``Schedule 1'' chemicals per calendar year (15 CFR 712.4);
(6) Require advance notification and annual reporting of all
imports and exports of ``Schedule 1'' chemicals to, or from, other
States Parties to the Convention (15 CFR 712.6, 742.18(a)(1) and
745.1); and
(7) Prohibit the export of ``Schedule 1'' chemicals to States not
Party to the Convention (15 CFR 742.18(a)(1) and (b)(1)(ii)).
In order to assist in determining whether the legitimate commercial
firms in the United States are significantly harmed by the limitations
of the Convention on access to, and production of, ``Schedule 1''
chemicals as described in this notice, BIS is seeking public comments
on any effects that implementation of the Chemical Weapons Convention,
through the Chemical Weapons Convention Implementation Act and the
Chemical Weapons Convention Regulations, has had on commercial
2007. In response to last year's notice of inquiry, BIS received
comments from two companies. To allow BIS to properly evaluate the
significance of any harm to commercial activities involving ``Schedule
1'' chemicals, public comments submitted in response to this notice of
inquiry should include both a quantitative and qualitative assessment
of the impact of the CWC on such activities.
All comments must be submitted to the address indicated in this
notice. The Department requires that all comments be submitted in
The Department encourages interested persons who wish to comment to
comments will close on December 17, 2007. The Department will consider
received after the end of the comment period will be considered if
possible, but their consideration cannot be assured. The Department
will not accept comments accompanied by a request that a part or all of
the material be treated confidentially because of its business
proprietary nature or for any other reason. The Department will return
such comments and materials to the persons submitting the comments and
will not consider them. All comments submitted in response to this
notice will be a matter of public record and will be available for
Office of Administration, at (202) 482-1093, for assistance.
[FR Doc. E7-22386 Filed 11-14-07; 8:45 am]